Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


Articles published in Am J Gastroenterol

Retrieve available abstracts of 34 articles:
HTML format
Text format



Single Articles


    February 2017
  1. KARIMI-SARI H, Tajik M, Bayatpoor ME, Alavian SM, et al
    Increasing the Awareness of the General Population: An Important Step in Elimination Programs of Viral Hepatitis.
    Am J Gastroenterol. 2017;112:393-395.
    PubMed     Text format    


  2. HUANG YW, Hsieh AC, Yang SS
    Safety of Statins in Chronic Hepatitis B Patients.
    Am J Gastroenterol. 2017;112:385-386.
    PubMed     Text format    


  3. TAKYAR V, Kleiner DE, Koh C
    A Wolf in Sheep's Clothing in the Era of Non-Invasive Staging: Non-Hodgkin's Lymphoma Masquerading as Serologic HCV Cirrhosis.
    Am J Gastroenterol. 2017;112:398-399.
    PubMed     Text format    


  4. LO GH
    Did Statins Really Reduce the Risk of Cirrhosis and Decompensation in Chronic Hepatitis B Patients?
    Am J Gastroenterol. 2017;112:386-387.
    PubMed     Text format    


  5. YANG JD, Mohamed HA, Cvinar JL, Gores GJ, et al
    Corrigendum: Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.
    Am J Gastroenterol. 2017;112:402.
    PubMed     Text format    


    December 2016
  6. GARCIA-SAENZ-DE-SICILIA M, Duvoor C, Altamirano J, Chavez-Araujo R, et al
    A Day-4 Lille Model Predicts Response to Corticosteroids and Mortality in Severe Alcoholic Hepatitis.
    Am J Gastroenterol. 2016 Dec 6. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  7. PILLAI AA, Anania FA, Pearlman BL
    Caution: Reactivation of Hepatitis B during Hepatitis C Treatment with Direct-Acting Antiviral Therapy.
    Am J Gastroenterol. 2016;111:1854-1856.
    PubMed     Text format    


  8. SETO WK, Wong DH, Chan TY, Hwang YY, et al
    Erratum: Association of Hepatitis B Core-Related Antigen With Hepatitis B Virus Reactivation in Occult Viral Carriers Undergoing High-Risk Immunosuppressive Therapy.
    Am J Gastroenterol. 2016;111:1858.
    PubMed     Text format    


    November 2016
  9. HUANG YW, Hsieh AC, Yang SS
    Statins and the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients.
    Am J Gastroenterol. 2016;111:1655-1656.
    PubMed     Text format    


  10. HU YW
    Statins and the Risk of Cirrhosis in Chronic Hepatitis B Patients.
    Am J Gastroenterol. 2016;111:1655.
    PubMed     Text format    


    October 2016
  11. CHO HJ, Kim B, Lee JD, Kang DR, et al
    Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver.
    Am J Gastroenterol. 2016 Oct 25. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


    September 2016
  12. SETO WK, Wong DH, Chan TY, Hwang YY, et al
    Association of Hepatitis B Core-Related Antigen With Hepatitis B Virus Reactivation in Occult Viral Carriers Undergoing High-Risk Immunosuppressive Therapy.
    Am J Gastroenterol. 2016 Sep 20. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


    August 2016
  13. YANG JD, Mohamed HA, Cvinar JL, Gores GJ, et al
    Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.
    Am J Gastroenterol. 2016 Aug 16. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


    July 2016
  14. CHANG CY, Aziz N, Poongkunran M, Javaid A, et al
    Serum Alanine Aminotransferase and Hepatitis B DNA Flares in Pregnant and Postpartum Women with Chronic Hepatitis B.
    Am J Gastroenterol. 2016 Jul 26. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  15. SHIFFMAN ML, Rustgi V, Bennett M, Forns X, et al
    Corrigendum: Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir With or Without Ribavirin in HCV-Infected Patients Taking Concomitant Acid-Reducing Agents.
    Am J Gastroenterol. 2016;111:1077.
    PubMed     Text format    


    June 2016
  16. AHN J, Lim JK, Lee HM, Lok AS, et al
    Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study.
    Am J Gastroenterol. 2016 Jun 21. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  17. SCHITZ A, Moser S, Marchart K, Haltmayer H, et al
    Direct Observed Therapy of Chronic Hepatitis C With Interferon-Free All-Oral Regimens at a Low-Threshold Drug Treatment Facility-a New Concept for Treatment of Patients With Borderline Compliance Receiving Opioid Substitution Therapy.
    Am J Gastroenterol. 2016;111:903-5.
    PubMed     Text format    


    May 2016
  18. HUANG YW, Lee CL, Yang SS, Fu SC, et al
    Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study.
    Am J Gastroenterol. 2016 May 10. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  19. STERN R, Hametner S, Ramona AZ, Moser S, et al
    Interferon/Ribavirin-Free Antiviral Treatment in Septuagenarians and Octogenarians With Chronic Hepatitis C.
    Am J Gastroenterol. 2016;111:744-5.
    PubMed     Text format    


    April 2016
  20. SHIFFMAN ML, Rustgi V, Bennett M, Forns X, et al
    Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir With or Without Ribavirin in HCV-Infected Patients Taking Concomitant Acid-Reducing Agents.
    Am J Gastroenterol. 2016 Apr 5. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  21. WANG CC, Tseng KC, Hsieh TY, Tseng TC, et al
    Assessing the Durability of Entecavir-Treated Hepatitis B Using Quantitative HBsAg.
    Am J Gastroenterol. 2016 Apr 5. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  22. SENATORE FJ, McDonald K
    Pitfalls of Treating Alcoholic Hepatitis: Recognizing Hemolytic Anemia in Zieve's Syndrome.
    Am J Gastroenterol. 2016;111:577-9.
    PubMed     Text format    


    March 2016
  23. YOUNOSSI ZM, Stepanova M, Henry L, Nader F, et al
    An In-Depth Analysis of Patient-Reported Outcomes in Patients With Chronic Hepatitis C Treated With Different Anti-Viral Regimens.
    Am J Gastroenterol. 2016 Mar 29. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  24. SHI Y, Xia F, Li QJ, Li JH, et al
    Magnetic Resonance Elastography for the Evaluation of Liver Fibrosis in Chronic Hepatitis B and C by Using Both Gradient-Recalled Echo and Spin-Echo Echo Planar Imaging: A Prospective Study.
    Am J Gastroenterol. 2016 Mar 15. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  25. LIU KL, Shih IL, Huang YC, Chen CH, et al
    Image of the Month: Abdominoscrotal Hydrocele.
    Am J Gastroenterol. 2016;111:312.
    PubMed     Text format    


    February 2016
  26. PILLAI AA, Wedd J, Norvell JP, Parekh S, et al
    Simeprevir and Sofosbuvir (SMV-SOF) for 12 Weeks for the Treatment of Chronic Hepatitis C Genotype 1 Infection: A Real World (Transplant) Hepatology Practice Experience.
    Am J Gastroenterol. 2016 Feb 2. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  27. COLLYER E, Kay M
    Response to Fontana et al.
    Am J Gastroenterol. 2016;111:297.
    PubMed     Text format    


  28. FONTANA RJ
    Response to Collyer et al.
    Am J Gastroenterol. 2016;111:297-8.
    PubMed     Text format    


  29. TRAN TT, Ahn J, Reau NS
    ACG Clinical Guideline: Liver Disease and Pregnancy.
    Am J Gastroenterol. 2016;111:176-94.
    PubMed     Text format     Abstract available


    November 2015
  30. YANG JD, Gyedu A, Afihene MY, Duduyemi BM, et al
    Hepatocellular Carcinoma Occurs at an Earlier Age in Africans, Particularly in Association With Chronic Hepatitis B.
    Am J Gastroenterol. 2015;110:1629-31.
    PubMed     Text format    


    September 2015
  31. FONTANA RJ, Hayashi PH, Barnhart H, Kleiner DE, et al
    Persistent Liver Biochemistry Abnormalities Are More Common in Older Patients and those With Cholestatic Drug Induced Liver Injury.
    Am J Gastroenterol. 2015 Sep 8. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


    July 2015
  32. SHIFFMAN ML, James AM, Long AG, Alexander PC, et al
    Treatment of Chronic HCV With Sofosbuvir and Simeprevir in Patients With Cirrhosis and Contraindications to Interferon and/or Ribavirin.
    Am J Gastroenterol. 2015 Jul 28. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


  33. GORDON SC, Lamerato LE, Rupp LB, Holmberg SD, et al
    Prevalence of Cirrhosis in Hepatitis C Patients in the Chronic Hepatitis Cohort Study (CHeCS): A Retrospective and Prospective Observational Study.
    Am J Gastroenterol. 2015 Jul 28. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


    May 2015
  34. DHALIWAL HK, Hoeroldt BS, Dube AK, McFarlane E, et al
    Long-Term Prognostic Significance of Persisting Histological Activity Despite Biochemical Remission in Autoimmune Hepatitis.
    Am J Gastroenterol. 2015 May 26. doi: 10.1038/ajg.2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: